-
1
-
-
43049162220
-
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine
-
Chen S.L., Zhang J., Yei F., et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol. 126 (2008) 407-413
-
(2008)
Int J Cardiol.
, vol.126
, pp. 407-413
-
-
Chen, S.L.1
Zhang, J.2
Yei, F.3
-
2
-
-
46449137187
-
Prevention of radiocontrast media-induced acute renal failure
-
Rose B.D. (Ed), UpToDate, Wellesley
-
Rudnick M.R., and Tumlin J.A. Prevention of radiocontrast media-induced acute renal failure. In: Rose B.D. (Ed). UpToDate00 (2006), UpToDate, Wellesley
-
(2006)
UpToDate00
-
-
Rudnick, M.R.1
Tumlin, J.A.2
-
3
-
-
0028490756
-
Contrast nephrotoxicity
-
Barrett B.J. Contrast nephrotoxicity. J Am Soc Nephrol 5 (1994) 125-137
-
(1994)
J Am Soc Nephrol
, vol.5
, pp. 125-137
-
-
Barrett, B.J.1
-
4
-
-
3042852243
-
Prevention of radiocontrast-induced nephropathy
-
Asif A., and Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44 (2004) 12-24
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 12-24
-
-
Asif, A.1
Epstein, M.2
-
5
-
-
33745283670
-
Prophylaxis strategies for contrast-induced nephropathy
-
Pannu N., Wiebe N., and Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
-
(2006)
JAMA
, vol.295
, pp. 2765-2779
-
-
Pannu, N.1
Wiebe, N.2
Tonelli, M.3
-
6
-
-
0028936849
-
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial
-
Rudnick M.R., Goldfarb S., Wexler L., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47 (1995) 254-261
-
(1995)
Kidney Int
, vol.47
, pp. 254-261
-
-
Rudnick, M.R.1
Goldfarb, S.2
Wexler, L.3
-
7
-
-
0030661687
-
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality
-
McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
-
(1997)
Am J Med
, vol.103
, pp. 368-375
-
-
McCullough, P.A.1
Wolyn, R.2
Rocher, L.L.3
Levin, R.N.4
O'Neill, W.W.5
-
8
-
-
33646135329
-
Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients
-
Kian K., Wyatt C., Schon D., Packer J., Vassalotti J., and Mishler R. Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients. Kidney Int 69 (2006) 1444-1449
-
(2006)
Kidney Int
, vol.69
, pp. 1444-1449
-
-
Kian, K.1
Wyatt, C.2
Schon, D.3
Packer, J.4
Vassalotti, J.5
Mishler, R.6
-
9
-
-
0037059951
-
Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty
-
Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
-
(2002)
Arch Intern Med
, vol.162
, pp. 329-336
-
-
Mueller, C.1
Buerkle, G.2
Buettner, H.J.3
-
10
-
-
2442590642
-
Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial
-
Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
-
(2004)
JAMA
, vol.291
, pp. 2328-2334
-
-
Merten, G.J.1
Burgess, W.P.2
Gray, L.V.3
-
11
-
-
2442542222
-
Prevention of radiocontrast nephropathy: back to basics
-
Chertow G.M. Prevention of radiocontrast nephropathy: back to basics. JAMA 291 (2004) 2376-2377
-
(2004)
JAMA
, vol.291
, pp. 2376-2377
-
-
Chertow, G.M.1
-
12
-
-
10744229574
-
N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials
-
Kshirsagar A.V., Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 761-769
-
-
Kshirsagar, A.V.1
Poole, C.2
Mottl, A.3
-
13
-
-
0042466568
-
Acetylcysteine for prevention of contrast nephropathy: meta-analysis
-
Birck R., Krzossok S., Markowetz F., Schnulle P., van der Woude F.J., and Barun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598
-
(2003)
Lancet
, vol.362
, pp. 598
-
-
Birck, R.1
Krzossok, S.2
Markowetz, F.3
Schnulle, P.4
van der Woude, F.J.5
Barun, C.6
-
14
-
-
0347990333
-
Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials
-
Alonso A., Lau J., Jaber B.L., Weintraub A., and Sarnak M.J. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43 (2004) 1-9
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 1-9
-
-
Alonso, A.1
Lau, J.2
Jaber, B.L.3
Weintraub, A.4
Sarnak, M.J.5
-
15
-
-
1642545171
-
Systematic review of the impact of N-acetylcysteine on contrast nephropathy
-
Pannu N., Manns B., Lee H., and Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65 (2004) 1366-1374
-
(2004)
Kidney Int
, vol.65
, pp. 1366-1374
-
-
Pannu, N.1
Manns, B.2
Lee, H.3
Tonelli, M.4
-
16
-
-
18244395035
-
N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis
-
Liu R., Nair D., Ix J., Moore D.H., and Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med 20 (2005) 193-200
-
(2005)
J Gen Intern Med
, vol.20
, pp. 193-200
-
-
Liu, R.1
Nair, D.2
Ix, J.3
Moore, D.H.4
Bent, S.5
-
17
-
-
11344275793
-
Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis
-
Nallamothu B.K., Shojania K.G., Saint S., Hofer T.P., Humes H.D., Moscucci M., and Bates E.R. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117 (2004) 938-947
-
(2004)
Am J Med
, vol.117
, pp. 938-947
-
-
Nallamothu, B.K.1
Shojania, K.G.2
Saint, S.3
Hofer, T.P.4
Humes, H.D.5
Moscucci, M.6
Bates, E.R.7
-
18
-
-
29144523846
-
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials
-
Zagler A., Azadpour M., Mercado C., and Hennekens C.H. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 151 (2006) 140-145
-
(2006)
Am Heart J
, vol.151
, pp. 140-145
-
-
Zagler, A.1
Azadpour, M.2
Mercado, C.3
Hennekens, C.H.4
-
19
-
-
0037419923
-
Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial
-
Kay J., Chow W.H., Chan T.M., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289 (2003) 553-558
-
(2003)
JAMA
, vol.289
, pp. 553-558
-
-
Kay, J.1
Chow, W.H.2
Chan, T.M.3
-
20
-
-
0034691822
-
Prevention of radiographic-contrast-agent-induced reduction in renal function by acetylcysteine
-
Tepel M., Van Der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reduction in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
-
(2000)
N Engl J Med
, vol.343
, pp. 180-184
-
-
Tepel, M.1
Van Der Giet, M.2
Schwarzfeld, C.3
Laufer, U.4
Liermann, D.5
Zidek, W.6
-
21
-
-
0942265438
-
The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable
-
Hoffmann U., Fischereder M., Kruger B., Drobnik W., and Kramer B.K. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15 (2004) 407-410
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 407-410
-
-
Hoffmann, U.1
Fischereder, M.2
Kruger, B.3
Drobnik, W.4
Kramer, B.K.5
-
22
-
-
33745641529
-
N-acetylcysteine and contrast-induced nephropathy in primary angioplasty
-
Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354 (2006) 2773-2782
-
(2006)
N Engl J Med
, vol.354
, pp. 2773-2782
-
-
Marenzi, G.1
Assanelli, E.2
Marana, I.3
-
23
-
-
10744233453
-
Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
-
Briguori C., Colombo A., Violante A., et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25 (2004) 206-211
-
(2004)
Eur Heart J
, vol.25
, pp. 206-211
-
-
Briguori, C.1
Colombo, A.2
Violante, A.3
|